The US Preventive Services Task Force (USPSTF) has posted a draft updated statement on cervical cancer screening. The ...

Screening recommended every three years with cervical cytology for women aged 21 to 29 years, every five years with hrHPV screening at age 30 to 65 years.

Much of the rest of the draft recommendation statement aligns with previous recommendations, which were last updated in 2018.

The U.S. Preventive Services Task Force pitched an update to its guidelines for cervical cancer screening, endorsing HPV ...

Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred ...

The USPSTF guidance follows the U.S. Food and Drug Administration's approval of a self-testing kit for cervical cancer last May. That test should be repeated every five years from age 30 until 65, ...

A new proposal recommends replacing routine pap smears with HPV testing every five years for women over 30, signaling a serious shift in cervical cancer screening guidelines.

The U.S. Preventative Services Task Force has drafted a new recommendation for cervical cancer screening.The biggest change: ...

The U.S. Preventive Services Task Force has introduced a new recommendation that women should undergo HPV testing every five ...

The USPSTF recommends cervical cancer screening every 3 years with cervical cytology alone in women ages 21 to 29 years and every 5 years with hrHPV primary screening for women aged 30 to 65 years.